Responding to demand from surgeons for faster turnaround times and more precise design benefits, MedCAD is converting its production of all metal products—including AccuPlate reconstruction plates for the mandible and AccuShape Ti cranioplasty products—to 3D printing technology only. MedCAD’s new U.S. Food and Drug Administration-cleared AccuStride product line for foot and ankle will all also feature 3D printed titanium.

3D-printed titanium plates have faster delivery times and generally contain additional geometries and features to address more surgical needs and complexities. 

“MedCAD continues to invest in and expand 3D titanium printing capabilities, enabling us to commit to faster delivery times and better design features for surgeons for high-demand implants,” MedCAD President/CEO Nancy Hairston said. “These improved turnaround times for each patient-specific plate can quickly provide surgeons with bespoke, creative reconstruction options within timeframes that were previously unavailable.”

MedCAD has fully converted all titanium products to the latest manufacturing technologies in 3D printed metals to deliver enhanced performance and value, and faster delivery times.

All PEEK products, including AccuShape PEEK Cranial Implants, will continue to be manufactured using traditional computer numeric control (CNC) milling technology.

MedCAD is a Dallas-based, privately held medical technology company built on an innovative approach to designing and producing patient-matched medical devices. Harnessing precise imaging, surgical experience, and advanced design and manufacturing technologies, MedCAD creates personalized, patient-matched medical devices and surgical plans for cranial defects, oral surgery, CMF trauma and reconstructive surgical procedures. The AccuPlate patient-matched titanium implants creator’s approach is totally patient-customized, with every device and every procedure planned and manufactured in-house in cooperation with a patient’s surgeon.